Ran D. Balicer

16.9k total citations · 6 hit papers
261 papers, 8.8k citations indexed

About

Ran D. Balicer is a scholar working on Epidemiology, Infectious Diseases and General Health Professions. According to data from OpenAlex, Ran D. Balicer has authored 261 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Epidemiology, 54 papers in Infectious Diseases and 47 papers in General Health Professions. Recurrent topics in Ran D. Balicer's work include SARS-CoV-2 and COVID-19 Research (23 papers), Vaccine Coverage and Hesitancy (21 papers) and Disaster Response and Management (17 papers). Ran D. Balicer is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (23 papers), Vaccine Coverage and Hesitancy (21 papers) and Disaster Response and Management (17 papers). Ran D. Balicer collaborates with scholars based in Israel, United States and United Kingdom. Ran D. Balicer's co-authors include Noa Dagan, Marc Lipsitch, Noam Barda, Ben Y. Reis, Miguel A. Hernán, Eldad Kepten, Oren Miron, Mark A. Katz, Isaac S. Kohane and Daniel J. Barnett and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Ran D. Balicer

255 papers receiving 8.6k citations

Hit Papers

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vacci... 2021 2026 2022 2024 2021 2021 2021 2022 2021 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ran D. Balicer Israel 42 3.4k 1.4k 1.3k 933 882 261 8.8k
Kumanan Wilson Canada 48 2.6k 0.8× 2.0k 1.4× 2.3k 1.7× 1.8k 1.9× 483 0.5× 305 9.7k
Rebecca L. Morgan United States 46 2.5k 0.7× 694 0.5× 3.1k 2.3× 756 0.8× 1.2k 1.4× 185 11.6k
Chris Robertson United Kingdom 55 2.5k 0.7× 901 0.6× 2.6k 2.0× 792 0.8× 1.2k 1.4× 272 11.7k
Jamie Lopez Bernal United Kingdom 38 4.3k 1.3× 1.7k 1.2× 1.5k 1.1× 888 1.0× 599 0.7× 93 9.8k
Charles Shey Wiysonge South Africa 50 2.6k 0.8× 3.6k 2.5× 2.3k 1.7× 1.7k 1.8× 614 0.7× 361 9.6k
Tom Jefferson United Kingdom 47 2.1k 0.6× 1.4k 1.0× 5.0k 3.7× 1.3k 1.4× 446 0.5× 182 11.7k
Robert Booy Australia 55 2.9k 0.9× 1.8k 1.3× 5.8k 4.3× 695 0.7× 384 0.4× 317 12.5k
Manfred S. Green Israel 49 1.7k 0.5× 646 0.4× 1.5k 1.1× 879 0.9× 764 0.9× 309 9.6k
Jennifer M. McGoogan China 21 7.5k 2.2× 329 0.2× 1.6k 1.2× 685 0.7× 601 0.7× 43 12.6k
Mark Jones Australia 55 1.1k 0.3× 460 0.3× 3.1k 2.3× 1.0k 1.1× 1.2k 1.3× 299 12.1k

Countries citing papers authored by Ran D. Balicer

Since Specialization
Citations

This map shows the geographic impact of Ran D. Balicer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran D. Balicer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran D. Balicer more than expected).

Fields of papers citing papers by Ran D. Balicer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ran D. Balicer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran D. Balicer. The network helps show where Ran D. Balicer may publish in the future.

Co-authorship network of co-authors of Ran D. Balicer

This figure shows the co-authorship network connecting the top 25 collaborators of Ran D. Balicer. A scholar is included among the top collaborators of Ran D. Balicer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ran D. Balicer. Ran D. Balicer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fowlkes, Ashley, Alon Peretz, David Greenberg, et al.. (2024). Randomised immunogenicity trial comparing 2019-2020 recombinant and egg-based influenza vaccines among frequently vaccinated healthcare personnel in Israel. International Journal of Infectious Diseases. 149. 107260–107260. 1 indexed citations
2.
Shapira, Bracha, et al.. (2024). Trends of common laboratory biomarkers after SARS-CoV-2 infection. Journal of Infection. 89(6). 106318–106318.
4.
Miron, Oren, Noam Barda, Ran D. Balicer, Ariel Kor, & Shaul Lev‐Ran. (2022). Association of opioid use disorder with healthcare utilization and cost in a public health system. Addiction. 117(11). 2880–2886. 15 indexed citations
5.
Hayek, Samah, Yatir Ben‐Shlomo, Eldad Kepten, et al.. (2022). Indirect protection of children from SARS-CoV-2 infection through parental vaccination. Science. 375(6585). 1155–1159. 34 indexed citations
6.
Cohen-Stavi, Chandra J., Noam Barda, Shlomit Yaron, et al.. (2022). BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age. New England Journal of Medicine. 387(3). 227–236. 53 indexed citations
8.
Mittelman, Moshe, Noam Barda, Noa Dagan, et al.. (2021). Effectiveness of the BNT162b2mRNA COVID-19 vaccine in patients with hematological neoplasms in a nationwide mass vaccination setting. Blood. 139(10). 1439–1451. 43 indexed citations
9.
Leader, Avi, Noa Dagan, Noam Barda, et al.. (2021). Previously undiagnosed cancer in patients with arterial thrombotic events – A population‐based cohort study. Journal of Thrombosis and Haemostasis. 20(3). 635–647. 7 indexed citations
10.
Dagan, Noa, Noam Barda, Eldad Kepten, et al.. (2021). BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. New England Journal of Medicine. 384(15). 1412–1423. 1619 indexed citations breakdown →
11.
Lipsitch, Marc, Florian Krammer, Gili Regev‐Yochay, Yaniv Lustig, & Ran D. Balicer. (2021). SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact. Nature reviews. Immunology. 22(1). 57–65. 194 indexed citations breakdown →
12.
Barda, Noam, Gal Yona, Guy N. Rothblum, et al.. (2020). Addressing bias in prediction models by improving subpopulation calibration. Journal of the American Medical Informatics Association. 28(3). 549–558. 40 indexed citations
13.
Dagan, Noa, Eldad Elnekave, Noam Barda, et al.. (2020). Automated opportunistic osteoporotic fracture risk assessment using computed tomography scans to aid in FRAX underutilization. Nature Medicine. 26(1). 77–82. 74 indexed citations
14.
Reges, Orna, Moshe Hoshen, Philip Greenland, et al.. (2020). <p>Combining Inpatient and Outpatient Data for Diagnosis of Non-Valvular Atrial Fibrillation Using Electronic Health Records: A Validation Study</p>. Clinical Epidemiology. Volume 12. 477–483. 15 indexed citations
15.
Miron, Oren, et al.. (2020). Rising opioid prescription fulfillment among non-cancer and non-elderly patients—Israel’s alarming example. Regional Anesthesia & Pain Medicine. 46(5). 455–456. 17 indexed citations
16.
Barda, Noam, Dan Riesel, Joseph Levy, et al.. (2020). Developing a COVID-19 mortality risk prediction model when individual-level data are not available. Nature Communications. 11(1). 4439–4439. 77 indexed citations
17.
Cohen-Stavi, Chandra J., et al.. (2020). Mixed Methods Evaluation of Reasons Why Care Deviates From Clinical Guidelines Among Patients With Multimorbidity. Medical Care Research and Review. 79(1). 102–113. 6 indexed citations
18.
Singer, Shepherd Roee, Moshe Hoshen, Efrat Shadmi, et al.. (2012). EMR-based medication adherence metric markedly enhances identification of nonadherent patients.. PubMed. 18(10). e372–7. 23 indexed citations
19.
Cohen, Arnon D., Jacob Dreiher, Margalit Goldfracht, et al.. (2011). [The effect of the introduction of pneumococcal vaccination for adults as a quality measure on vaccination rates in Clalit Health Services].. PubMed. 150(7). 578–82, 617. 2 indexed citations
20.
Cohen, Arnon D., et al.. (2010). [The quality indigators program in Clalit Health Services: the first decade].. PubMed. 149(4). 204–9, 265. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026